Перейти к содержимому

Quality by Design (QbD) in Pharmaceutical Manufacturing | QTPP, CQA, CMA, CPP & Control Strategy

Pharmatalks

0:00 / 0:00

Quality by Design (QbD) in Pharmaceutical Manufacturing | QTPP, CQA, CMA, CPP & Control Strategy

177 просмотров · 3 недели назад
Pharmatalks
11,6 тыс. подписчиков
177 просмотров · 3 недели назад
What does Quality by Design (QbD) really mean in pharmaceutical manufacturing? In this complete Pharmatalks guide, we take you step by step through the QbD lifecycle — from defining the Quality Target Product Profile (QTPP) to identifying CQAs, CMAs, and CPPs, performing risk assessment, using DOE, and finally building an effective control strategy. You’ll learn how pharmaceutical quality can be built into the product and manufacturing process instead of relying only on end-product testing. What You’ll Learn Quality by Design fundamentals QTPP and product quality targets Critical Quality Attributes — CQAs Critical Material Attributes — CMAs Critical Process Parameters — CPPs CMA–CQA and CPP–CQA relationships Pharmaceutical risk assessment FMEA and risk matrices Process understanding Design of Experiments — DOE Interaction effects Control strategy Process Analytical Technology — PAT Real-time process monitoring Scale-up using QbD Continued Process Verification — CPV Continuous improvement and lifecycle management Chapters / Timeline 00:00 — QbD Fundamentals & Lifecycle Slides 1–10: What is QbD, traditional quality vs QbD, QbD mindset, patient needs, and lifecycle thinking. 04:59 — QTPP & Critical Quality Attributes Slides 11–20: QTPP, CQAs, tablet quality attributes, dissolution, impurities, and CQA risk ranking. 10:11 — CMAs & Critical Process Parameters Slides 21–30: Material attributes, API particle size, excipient variability, CPPs, granulation, and tablet compression. 15:27 — Risk Assessment, FMEA & DOE Slides 31–40: Risk assessment, risk scoring, FMEA, Ishikawa analysis, knowledge management, process understanding, DOE, and interaction effects. 20:48 — Control Strategy & Lifecycle Improvement Slides 41–50: Control strategy, PAT, real-time monitoring, scale-up, continued process verification, regulatory value, and continuous improvement. Who Should Watch? This video is useful for: Pharmaceutical QA professionals QC analysts Validation specialists Formulation and R&D scientists Process engineers Production professionals Regulatory Affairs teams Pharmaceutical students Anyone preparing for pharma technical interviews Follow Pharmatalks for practical videos on pharmaceutical manufacturing, GMP, validation, quality systems, HPLC, cleanrooms, and pharmaceutical career development. #QualityByDesign #QbD #PharmaceuticalManufacturing #Pharma #GMP #QTPP #CQA #CMA #CPP #ProcessValidation #QualityAssurance #PharmaceuticalQuality #RiskAssessment #FMEA #DOE #PAT #Pharmatalks